These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26339360)

  • 1. Simulated microgravity affects ciprofloxacin susceptibility and expression of acrAB-tolC genes in E. coli ATCC25922.
    Xu B; Li C; Zheng Y; Si S; Shi Y; Huang Y; Zhang J; Cui Y; Cui Y
    Int J Clin Exp Pathol; 2015; 8(7):7945-52. PubMed ID: 26339360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
    Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
    Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol controls Escherichia coli growth by inhibiting the AcrAB-TolC efflux pump.
    Hwang D; Lim YH
    FEMS Microbiol Lett; 2019 Feb; 366(4):. PubMed ID: 30753439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli.
    Gerken H; Misra R
    Mol Microbiol; 2004 Nov; 54(3):620-31. PubMed ID: 15491355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of concentration gradient carbapenem exposure on expression of bla
    Chetri S; Bhowmik D; Dhar D; Chakravarty A; Bhattacharjee A
    Infect Genet Evol; 2019 Sep; 73():332-336. PubMed ID: 31170528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli.
    Chetri S; Bhowmik D; Paul D; Pandey P; Chanda DD; Chakravarty A; Bora D; Bhattacharjee A
    BMC Microbiol; 2019 Sep; 19(1):210. PubMed ID: 31488061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.
    Goswami M; Subramanian M; Kumar R; Jass J; Jawali N
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4369-74. PubMed ID: 27139480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of gene expression associated with both the AcrAB/TolC system and the membrane permeability, in Salmonella spp isolates with and without gyrA mutation].
    Galiana A; Sánchez-Guillén L; Rodríguez JC; Cremades R; Santibañez M; Ferrari R; Ruiz-García M; López P; Royo G
    Rev Esp Quimioter; 2014 Dec; 27(4):239-43. PubMed ID: 25536427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
    Langevin AM; El Meouche I; Dunlop MJ
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
    Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
    Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
    Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
    Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance.
    Swick MC; Morgan-Linnell SK; Carlson KM; Zechiedrich L
    Antimicrob Agents Chemother; 2011 Feb; 55(2):921-4. PubMed ID: 21098250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active efflux of antibiotics as multiple-antibiotic-resistance mechanism in clinical strains of escherichia coli].
    Zhang X; Li J
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):614-7. PubMed ID: 11798829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system.
    Touzé T; Eswaran J; Bokma E; Koronakis E; Hughes C; Koronakis V
    Mol Microbiol; 2004 Jul; 53(2):697-706. PubMed ID: 15228545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress Introduction Rate Alters the Benefit of AcrAB-TolC Efflux Pumps.
    Langevin AM; Dunlop MJ
    J Bacteriol; 2018 Jan; 200(1):. PubMed ID: 29038251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
    Sato T; Yokota S; Okubo T; Ishihara K; Ueno H; Muramatsu Y; Fujii N; Tamura Y
    J Vet Med Sci; 2013 May; 75(4):407-14. PubMed ID: 23149545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.
    Dean CR; Narayan S; Daigle DM; Dzink-Fox JL; Puyang X; Bracken KR; Dean KE; Weidmann B; Yuan Z; Jain R; Ryder NS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3129-35. PubMed ID: 16048914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.